Want to use our logo?

Download the ICS Branding Pack

ICS Background

Prof Karl-Erik Andersson
Wake Forest Institute fir Regenerative Medicine, Wake Forest University School of Medicine

View ICS Advisory Board Member Details

Karl-Erik Andersson

ICS Advisory Board Member

Profession:Clinical Pharmacologist
You must be logged in to view this contact
to ICS

Curriculum vitae Dr. Karl-Erik Andersson was born and raised in Sweden. He received his medical degree from the University of Lund in 1968, where he subsequently worked as a lecturer in Clinical Pharmacology. He completed his Ph.D. at the Department of Pharmacology, Lund University, in 1973. In 1975 he obtained a Swedish specialist degree in Internal Medicine and was appointed as Professor of Clinical Pharmacology at the University of Odense, Denmark. From 1976 to 1978 he had the same position at the University of Aarhus, Denmark. From 1978-2006 he was Professor and Chairman of the Department of Clinical Pharmacology, University of Lund, Lund, Sweden. He has been visiting professor at the Department of Obstetrics and Gynecology, University of Toronto (1983-1985) and at the Department of Urology, University of Virginia, Charlottesville, USA (1997-1998), and at the University of Aarhus, Aarhus, Denmark (2014-2017). From 2005 to 2019 Dr Andersson was professor at Wake Forest Institute for Regenerative Medicine at the Wake Forest University, Winston Salem, North Carolina. Currently Dr. Andersson is Professor Emeritus at the Universities of Lund and Wake Forest. He is a member of many international societies including the American Urological Association, the European Association of Urology, and the International Society for Sexual and Impotence Research. He has served as section editor of Investigative Urology (Journal of Urology (2008-2016), and is currently section editior for Neurourology and Urodynamic and World Journal of Urology. He is deputy editor-in chief for International Journal of Neurourology. During his career, Dr. Andersson has authored more than 900 articles in peer-reviewed international journals. His research interests include urogenital and cardiovascular pharmacology and physiology, clinical trials, regenerative medicine and regenerative pharmacology.

Prof Karl-Erik Andersson declared on the Tuesday 6th February 2024 that they did not have any existing or known future financial relationships or affiliations to disclose (NONE).